Mallinckrodt Pharmaceuticals aims to support community development through its charitable giving. The mission focuses on enhancing health and wellness by improving access to healthcare and addressing specific community health needs, promoting science education by supporting STEM initiatives, and fostering economic growth by backing innovative life sciences research and development projects.
The Investigator Initiated Research (IIR) program at Mallinckrodt Pharmaceuticals seeks to fund research that advances the understanding of diseases and the therapeutic outcomes of the company's marketed and investigational products. The grant supports independent and collaborative projects that align with the company's interest in specific disease areas, aiming to deepen the scientific and medical knowledge base.